Sequential Fluorescence Recognition of Molybdenum(VI), Arsenite, and Phosphate Ions in a Ratiometric Manner: A Facile Approach for Discrimination of AsO2 - and H2PO4. ACS OMEGA 2019;4:10877-10890. [PMID: 31460185 PMCID: PMC6648501 DOI: 10.1021/acsomega.9b00377]

An amide-based smart probe (L) is explored for nanomolar detection of Mo(VI) ion in a ratiometric manner, involving hydrogen-bond-assisted chelation-enhanced fluorescence process through inhibition of photoinduced electron transfer process. The recognition of Mo(VI) is associated with a 17-fold fluorescence enhancement and confirmed by single-crystal X-ray diffraction of the resulting Mo(VI) complex (M1). Further, M1 selectively recognizes arsenite through green emission of their adduct (C1) with an 81-fold fluorescence enhancement. Interestingly, dihydrogen phosphate causes dissociation of C1 back to free L having weak fluorescence. The methods are fast, highly selective, and allow their bare eye visualization at physiological pH. All of the interactions have been substantiated by time-dependent density functional theory calculations to rationalize their spectroscopic properties. The corresponding lowest detection limits are 1.5 × 10-8 M for Mo(VI), 1.2 × 10-10 M for AsO2 -, and 3.2 × 10-6 M for H2PO4 -, whereas the respective association constants are 4.21 × 105 M-1 for Mo(VI), 6.49 × 104 M-1 for AsO2 -, and 2.11 × 105 M-1 for H2PO4 -. The L is useful for efficient enrichment of Mo(VI) from aqueous solution, while M1 efficiently removes AsO2 - from environmental samples by solid-phase extraction.

Assay format as a critical success factor for identification of novel inhibitor chemotypes of tissue-nonspecific alkaline phosphatase from high-throughput screening

The tissue-nonspecific alkaline phosphatase (TNAP) isozyme is centrally involved in the control of normal skeletal mineralization and pathophysiological abnormalities that lead to disease states such as hypophosphatasia, osteoarthritis, ankylosis and vascular calcification. TNAP acts in concert with the nucleoside triphosphate pyrophosphohydrolase-1 (NPP1) and the Ankylosis protein to regulate the extracellular concentrations of inorganic pyrophosphate (PP(i)), a potent inhibitor of mineralization. In this review we describe the serial development of two miniaturized high-throughput screens (HTS) for TNAP inhibitors that differ in both signal generation and detection formats, but more critically in the concentrations of a terminal alcohol acceptor used. These assay improvements allowed the rescue of the initially unsuccessful screening campaign against a large small molecule chemical library, but moreover enabled the discovery of several unique classes of molecules with distinct mechanisms of action and selectivity against the related placental (PLAP) and intestinal (IAP) alkaline phosphatase isozymes. This illustrates the underappreciated impact of the underlying fundamental assay configuration on screening success, beyond mere signal generation and detection formats.